Clinical Trials on Crigler Najjar Syndrome, Type 1
Total 7023 results
-
Assistance Publique - Hôpitaux de ParisUnknownChildren | Crigler Najjar SyndromeFrance
-
Promethera TherapeuticsCompletedUrea Cycle Disorders | Crigler Najjar SyndromeBelgium
-
University Medical Center GroningenErasmus Medical Center; De Najjar StichtingCompleted
-
Promethera TherapeuticsCompletedUrea Cycle Disorders | Crigler Najjar SyndromeIsrael, United Kingdom, Belgium, France, Italy
-
Audentes TherapeuticsCompletedCrigler-Najjar SyndromeIsrael, United States, United Kingdom
-
GenethonRecruitingCrigler-Najjar SyndromeItaly, France, Netherlands
-
Audentes TherapeuticsTerminatedCrigler-Najjar SyndromeIsrael, United States, United Kingdom
-
Swedish Medical CenterWithdrawnLevator Ani SyndromeUnited States
-
Cellaion SAEnrolling by invitationUrea Cycle Disorder | Crigler-Najjar Syndrome | Acute on Chronic Liver FailureBelgium, Spain, France, Bulgaria, Poland
-
Walter Reed Army Medical CenterUnknownLevator Ani Syndrome With Pain and/or Constipation Symptoms.United States
-
Medical University of SilesiaCompletedMyofascial Trigger Point Pain | Myofascial Pain Syndrome of Neck | Myofascial Trigger Point SyndromePoland
-
University of Texas Southwestern Medical CenterRecruitingGlucose Transporter Type 1 Deficiency Syndrome | GLUT1 Deficiency Syndrome | Glucose Transporter type1 (GLUT-1) Deficiency | GLUT-1 Deficiency SyndromeUnited States
-
University of Texas Southwestern Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS)Active, not recruitingGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1United States
-
Juan PascualNational Institute of Neurological Disorders and Stroke (NINDS)CompletedGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1United States
-
University of Texas Southwestern Medical CenterRecruitingGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1 | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport DefectUnited States
-
Riphah International UniversityCompletedMyofascial Trigger Point Pain | Quadratus Lumborum Syndrome | Positional Fault of Pelvis | Myofascial Trigger Point in Quadratus LumborumPakistan
-
University of British ColumbiaUltragenyx Pharmaceutical IncUnknownGlucose Transporter Type 1 Deficiency SyndromeCanada
-
Juan PascualNo longer availableGlucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency SyndromeUnited States
-
Juan PascualCompletedGlucose Transporter Type 1 Deficiency Syndrome | GLUT1 Deficiency SyndromeUnited States
-
Juan PascualWithdrawnGlucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency SyndromeUnited States
-
Juan PascualActive, not recruitingGlucose Transporter Type 1 Deficiency Syndrome | GLUT1DS1United States
-
European University CyprusCompletedMyofascial Pain Syndrome | Myofascial Trigger Point Pain | Upper Trapezius Trigger PointsCyprus
-
National Cheng-Kung University HospitalCompletedThe Comorbidity Between the Trigger Digit and Carpal Tunnel SyndromeTaiwan
-
SpirecutArcher ResearchCompletedCarpal Tunnel Syndrome | Trigger Finger | Trigger ThumbBelgium
-
Canadian Memorial Chiropractic CollegeUniversity of GuelphCompletedMyofascial Pain Syndrome | Myofascial Trigger Points | Trigger Points, MyofascialCanada
-
Nantes University HospitalUnknownLong QT Syndrome Type 1 or 2France
-
Merck Sharp & Dohme LLCWithdrawnHIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
-
Ultragenyx Pharmaceutical IncCompletedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, Australia, France, Israel, Italy, United Kingdom
-
Ultragenyx Pharmaceutical IncAvailableGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
-
Biruni UniversityHacettepe UniversityCompletedSubacromial Impingement Syndrome | Trigger Point Pain, MyofascialTurkey
-
CEU San Pablo UniversityCompletedEffects of Dry Needling on Neck and Shoulder Pain in Orchestral Musicians: a Prospective Case SeriesMusculoskeletal Pain | Trigger Point Pain, Myofascial | Pain SyndromeSpain
-
Adrian LacyUltragenyx Pharmaceutical IncCompletedGlucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)United States
-
Mayo ClinicElgene ChemicalCompletedComplex Regional Pain Syndrome, Type 1United States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Institut de Recherches Cliniques de MontrealCompletedMetabolic Syndrome | Type 1 DiabetesCanada
-
Universidad Juárez Autónoma de TabascoCompletedMetabolic Syndrome | Insulin Resistance | Type 1 DiabetesMexico
-
University Hospitals Cleveland Medical CenterAllerganCompletedMyofascial Pain Syndromes | Trigger Point Pain, Myofascial | Myofascial Trigger Point PainUnited States
-
University of GiessenWithdrawnComplex Regional Pain Syndrome Type 1Germany
-
Universidad de LeónUniversidad Complutense de MadridCompletedMyofascial Pain Syndrome | Trigger Point Pain, MyofascialSpain
-
Ultragenyx Pharmaceutical IncTerminatedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, France, Germany, Italy, United Kingdom
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Legius SyndromeUnited States
-
Cairo UniversityNot yet recruitingMyofascial Pain Syndrome | Trigger Point Pain, Myofascial
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Hospices Civils de LyonRecruitingNeuropathic Pain | Complex Regional Pain Syndrome Type 1France
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
University of Sao PauloUnknownBreast Cancer | Myofascial Trigger PointBrazil
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Medical University InnsbruckUnknown